A two-day event packed with leading speakers, research and cutting-edge presentations on the latest advancements in the discovery & development of cancer immunotherapies.
Click here to learn more about the conference
Look into the future of digital science and innovation with industry leaders at the 3rd annual Nordic Digital Science & Innovation Day. Join us on 30 May in Copenhagen for this one-day event that unites scientists, R&D leaders, industry experts, and thought leaders at the forefront of R&D innovation.
Click here to learn more about the conference
The 2024 ASCO Annual Meeting is the most significant gathering of oncology professionals worldwide.
Click here to learn more about the conference
The World Vaccine Congress is the largest, most established meeting dedicated to vaccines. From basic research to commercial manufacture, this one meeting covers the whole vaccine value chain where science, government and manufacturers all come together to create groundbreaking progress.
Click here to learn more about the conference
This R&D Day will feature a series of talks from Evaxion’s scientists and bioinformaticians, providing insights into Evaxion’s validated AI-Immunology™ platform for vaccine target discovery, design and development. The different talks will be followed by Q&A sessions for participants to interact.
The event will highlight the unique predictive capabilities that differentiate the AI-Immunology™ platform and how these can help address severe unmet medical needs for patients with cancer and infectious diseases.
The agenda of the event will be available closer to the R&D Day.
The 8th Annual MarketsandMarkets Next-Gen Immuno-Oncology Conference is a premier event dedicated to advancing the field of immuno-oncology. Join us on 7-8 March 2024 in London, UK, where leading experts, researchers, and industry professionals will gather to shape the future of cancer treatment.
Click here to learn more about the conference
Join us for presenting companies, investor one-on-one meetings, and networking opportunities with attendees.
The 5th Biologics World Nordics 2024 event will bring together biologic and biosimilar developers and manufacturers, technology providers, CMOs and CROs from the Nordics region and beyond to explore partnership and technical collaboration opportunities, discuss best R&D and biomanufacturing practises, and debate growth strategies as Nordics developed biologics enter critical clinical phase II and III development stages.
Click here to learn more about the conference
The 17th Annual European Life Sciences CEO Forum (ELSF) will take place on February 28-29, 2024, at the Hilton Zurich Airport Hotel, Switzerland. The event will be part of the Sachs Spring Life Sciences Week, which will also incorporate the 17th Annual European Life Sciences CEO Forum.
Click here to learn more about the conference
The 5th Annual European HealthTech CEO Forum (EHTF) will take place on February 27, 2024, at the Hilton Zurich Airport Hotel, Switzerland. The event will be part of the Sachs Spring Life Sciences Week, which will also incorporate the 17th Annual European Life Sciences CEO Forum.
Click here to learn more about the conference
The 65th ASH Annual Meeting and Exposition will take place December 9-12, 2023, in San Diego, California, and online. Mark your calendars now to attend the world’s most comprehensive hematology event of the year, and look forward to Evaxion's presentation.
Connecting AI leaders to revolutionize drug discovery through advanced AI/ML and data-driven analytics
The 6th Biologics World Nordics 2023 event will bring together biologic and biosimilar developers and manufacturers, technology providers, CMOs and CROs from the Nordics region and beyond to explore partnership and technical collaboration opportunities, discuss best R&D and biomanufacturing practises, and debate growth strategies as Nordics developed biologics enter critical clinical phase II and III development stages.
Click here to learn more about the conference.
Hear from and meet with the leading experts in Biomarker discovery, development, and analysis to advance and accelerate drug development in oncology and immuno-related therapies.
Click here to learn more about the conference.
NextGen Omics 2023 features 4 outstanding programmes, bringing together Europe’s most successful omics research experts under one roof. The series provides an excellent networking platform which consists of key discussion topics in: Next Generation Sequencing & Clinical Diagnostics, Single Cell & Spatial Analysis, Synthetic Biology in Discovery & Therapeutics and Digital PCR & Liquid Biopsies
Click here to learn more about the conference.
- Welcome by Evaxion's Chief Scientific Officer, Birgitte Rønø
- Lay-man introduction to malignant melanoma, Prof. Adnan Khattak
- EVX-01 phase 1 results summary, Prof. Adnan Khattak
- EVX-01 phase 2 initial results, Prof. Adnan Khattak
- The potential of EVX-01 and PCVs in the treatment of cancer, Prof. Adnan Khattak
- Q&A
From 6th to 8th November 2023 leading biotech and biopharma companies and development teams will gather in Messe Munich to realise BIO-Europe 2023. The show floor will feature an elaborate curated product offering alongside immersive conference agenda. BIO-Europe 2023 will shed light on vital industry topics, including AI, pharmaceuticals, preventative medicine, big data and more.
Click here to learn more about the conference.
The ESMO Congress is the most influential oncology platform for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world. ESMO 2023 will disseminate the latest cutting-edge data, provide high-quality education and unparalleled networking opportunities for oncologists and other stakeholders from all around the world.
Click here to learn more about the conference.
The World Vaccine Congress Europe is the largest and most established European meeting on vaccine R&D.
Click here to learn more about the conference.
The mRNA Cancer Vaccine Summit 2023 comes to Boston as the community is on the cusp of something truly exciting. This is the first and only forum dedicated to showcasing mRNA cancer vaccine technology advances, translational insights and critical clinical updates from the global leaders working towards effective harnessing of neoantigens and developing successful tailor-made mRNA cancer vaccines. Unite with mRNA cancer vaccine, oncology and immune-oncology leaders and stay up to date about these innovative cancer therapies. With individualized neoantigen therapies showing critical promise in the clinic, neoantigen leaders unite to exhibit a whole-day dedicated to neoantigen discovery and identification, towards optimized discovery and development of personalized cancer vaccines to differentiate and fast track your pipelines.
Click here to learn more about the conference.
The purpose of the meeting is to exchange information among academia, industry, advocacy and federal agencies on the current status and the challenges to develop and license a CMV vaccine.
Click here to learn more about the meeting.
NIAID Conference Center
5601 Fisher Lane
Rockville, MD 20852
The 23rd International Pathogenic Neisseria Conference aims to bring together passionate scientists, emerging and experienced researchers and clinicians from all continents to discuss the clinical presentation, epidemiology, population genomics, vaccine research and development, host-pathogen interactions and gene regulation of these Neisseria species in order to keep abreast of the latest developments in this field. IPNC is a great opportunity for networking and forming collaborations for future work on pathogenic Neisseria species.
Click here to learn more about the conference.
Seventh International Cancer Immunotherapy Conference: Translating Science into Survival.
Click here to learn more about the conference.
Join vaccines leaders, experts and distinguished scientists in Europe, delivering breakthrough research, technologies & connecting global pharma, biotech and academia for high-level discussions on the latest innovations within the vaccines discovery, therapeutics & manufacturing.
Click here to learn more about the conference.
The R&D Day will feature a series of talks from Evaxion scientists and collaborators, sharing previously unreleased preclinical data highlighting the use of Evaxion’s proprietary genetic immune adjuvant (Antigen Presenting Cell targeting) technology. This technology has been shown to enhance vaccination effects for both DNA and mRNA vaccines across a range of therapeutic vaccine applications.
The event will be hosted with the possibility of physical attendance at Evaxion’s facilities in Hørsholm, Denmark and as a live webcast.
Please write to info@evaxion-biotech.com with the following details to sign up for the physical attendance for R&D day:
Subject: R&D Day
Message: Your full name
Dr Neergaards Vej 5F,
2970Hørsholm
Denmark
If you are a holder of an ADR (American depositary receipt – a US issued certificate representing shares in a foreign company for trade on American stock exchange) and wish to know what applies in terms of voting or giving proxy, please refer to your depositary agreement with your broker.
Notice of general meetings will be published on the company web-site. If you are a Danish holder of shares you can also sign up for future notices at https://virk.dk/
Evaxion will be presenting a scientific presentation on our antigen presenting cell targeting technology for this year's World Vaccine Congress.
Reach out to Neil Anderson, VP and Global Head of Business Development (nja@evaxion-biotech.com)
Evaxion will be presenting on-site at BIO Europe in Basel this year.
If you would like to connect with us, contact Neil Anderson, VP and Global Head of Business Development (nja@evaxion-biotech.com)
Dial-In Information:
Toll Free: 1-877-407-0792
Toll/International: 1-201-689-8263
Conference ID: 13720456
Dial-In Information:
Toll Free: 1-877-407-0792
Toll/International: 1-201-689-8263